VP of Sales Keith Nalepka of BioElectronics Corp., talks about international agreements, building long-term relationships, and improving awareness of the ActiPatch brand.
CEO Seamus Lagan of Rennova Health, Inc., gives an update on increased monthly revenues, upcoming 3rd quarter report, and details of reverse split authorization.
CEO Andrew Whelan of BioElectronics Corp, discusses details of the FDA Innovation Challenge on opioid use, ActiPatch international sales, and plans for growth.
CEO Seamus Lagan of Rennova Health, Inc., speaks about rural hospitals direction, producing revenues, and possible future acquisitions.
PainReliefMeds.com Resumes Credit Card Processing Issues Related to the Suspension of Credit Card Processing Have Been Resolved JACKSON CENTER, PA / ACCESSWIRE / August 15, 2018 / PainReliefMeds.com, the website which sells the…
Premier Biomedical Signs Agreement With Sales Group to Represent Premier's Topical Pain Relief Products to the Military Group Has Extensive Experience and Connections Within Military and Government Procurement Organization JACKSON…
Premier Biomedical, Inc. Uplisted to OTCQB BIEI Trading on OTCQB Effective July 27, 2018 JACKSON CENTER, PA / ACCESSWIRE / July 30, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI) a research based publicly…
CEO Seamus Lagan of Rennova Health, Inc., discusses recent dilution, how it will help grow revenues, and developing plans for future growth possibilities.
CEO Seamus Lagan of Rennova Health, Inc., gives an update on cash flow position, potential for revenue growth in 2018, and recent financial report.
CEO Seamus Lagan of Rennova Health, Inc., gives an update on their financial statement's delayed release, Jamestown Hospital acquisition potential, and plans for increasing revenues.
CEO Andrew Whelan of BioElectronics Corp, gives an update on progress of FDA clearances, cost effectiveness, and providing relief to those with chronic pain.
CEO Seamus Lagan of Rennova Health, Inc., discusses taking ownership of new hospital, recent financial statements, and planned shareholder meeting.